Gelesis Holdings Inc.
Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Furt… Read more
Gelesis Holdings Inc. (GLSHQ) - Total Liabilities
Latest total liabilities as of June 2023: $114.50 Million USD
Based on the latest financial reports, Gelesis Holdings Inc. (GLSHQ) has total liabilities worth $114.50 Million USD as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Gelesis Holdings Inc. - Total Liabilities Trend (2020–2022)
This chart illustrates how Gelesis Holdings Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Gelesis Holdings Inc. Competitors by Total Liabilities
The table below lists competitors of Gelesis Holdings Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Brooge Energy Limited
NASDAQ:BROGW
|
USA | $429.22 Million |
|
J Smart Co Contractors PLC
LSE:SMJ
|
UK | GBX27.73 Million |
|
Philippine Seven Corp
PSE:SEVN
|
Philippines | ₱24.20 Billion |
|
NOODLES & CO-A
BE:NO3
|
Germany | €336.65 Million |
|
Canamex Gold Corp
PINK:CNMXF
|
USA | $9.95 Million |
Liability Composition Analysis (2020–2022)
This chart breaks down Gelesis Holdings Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gelesis Holdings Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gelesis Holdings Inc. (2020–2022)
The table below shows the annual total liabilities of Gelesis Holdings Inc. from 2020 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $115.79 Million | -20.85% |
| 2021-12-31 | $146.30 Million | +253.45% |
| 2020-12-31 | $41.39 Million | -- |